Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Journal of Cardiac Failure|May 10, 2005
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)Mihai Gheorghiade, Cesare Orlandi, John C Burnett, et al.
European Heart Journal|June 25, 2022
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trialMasatsugu Hori, Jun Zhu, Yan Liang, et al.
Obesity (Silver Spring, Md.)|October 10, 2009
Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in periodIan Caterson, Walmir Coutinho, Nick Finer, et al.
The American Journal of Cardiology|March 25, 2008
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitusNagesh S Anavekar, Scott D Solomon, John J V McMurray, et al.
Journal of the American College of Cardiology|December 19, 2012
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trialJaved Butler, Haris Subacius, Muthiah Vaduganathan, et al.
European Heart Journal|January 21, 2017
Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registryElena Arbelo, Josep Brugada, Carina Blomström-Lundqvist, et al.
European Journal of Heart Failure|November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionJens Jakob Thune, James E Signorovitch, Lars Kober, et al.
International Journal of Cardiology|December 16, 2014
Cardiac medication during pregnancy, data from the ROPACTitia P E Ruys, Aldo Maggioni, Mark R Johnson, et al.
European Journal of Heart Failure|January 19, 2012
Targeting myocardial substrate metabolism in heart failure: potential for new therapiesHossein Ardehali, Hani N Sabbah, Michael A Burke, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 7, 2019
Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registryTosho Balabanski, Josep Brugada, Elena Arbelo, et al.
Pageof 8